{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T03:32:07Z","timestamp":1782617527361,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.canrad.2022.06.002","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:57:30Z","timestamp":1660006650000},"page":"803-807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Essais cliniques en Oncologie Radioth\u00e9rapie\u00a0: r\u00e9flexion m\u00e9thodologique"],"prefix":"10.1016","volume":"26","author":[{"given":"S.","family":"Gourgou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Azria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2022.06.002_bib0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.canrad.2021.08.007","article-title":"Guidelines for external radiotherapy and brachytherapy procedures: 3rd edition","volume":"26","author":"Giraud","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2022.06.002_bib0125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.canrad.2021.11.011","article-title":"Specificities of clinical research in radiotherapy","volume":"26","author":"Hennequin","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2022.06.002_bib0130","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1016\/S1470-2045(11)70379-5","article-title":"Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it?","volume":"13","author":"van Loon","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2022.06.002_bib0135","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2022.06.002_bib0140","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801\u00a0women in 17\u00a0randomised trials","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2022.06.002_bib0145","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ijrobp.2010.03.049","article-title":"70Gy versus 80Gy in localized prostate cancer: 5-year results of GETUG 06\u00a0randomized trial","volume":"80","author":"Beckendorf","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.06.002_bib0150","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2022.06.002_bib0155","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2022.06.002_bib0160","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrclinonc.2016.79","article-title":"Clinical development of new drug-radiotherapy combinations","volume":"13","author":"Sharma","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.canrad.2022.06.002_bib0170","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1200\/JCO.2016.71.7397","article-title":"Randomized Trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer","volume":"35","author":"Catton","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2022.06.002_bib0165","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2022.06.002_bib0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fonc.2017.00059","article-title":"R-IDEAL: a framework for systematic clinical evaluation of technical innovations in radiation oncology","volume":"7","author":"Verkooijen","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2022.06.002_bib0180","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(09)61116-8","article-title":"No surgical innovation without evaluation: the IDEAL recommendations","volume":"374","author":"McCulloch","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2022.06.002_bib0185","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1200\/JCO.2017.74.0720","article-title":"Bayesian adaptive randomization trial of passive scattering proton therapy and intensity-modulated photon radiotherapy for locally advanced non-small-cell lung cancer","volume":"36","author":"Liao","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2022.06.002_bib0190","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2022.06.002_bib0195","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1186\/s12885-016-2947-0","article-title":"Comparing conVEntional RadioTherapy with stereotactIC body radiotherapy in patients with spinAL metastases: study protocol for an randomized controlled trial following the cohort multiple randomized controlled trial design","volume":"16","author":"van der Velden","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2022.06.002_bib0200","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.annonc.2021.12.015","article-title":"External control arms in oncology: current use and future directions","volume":"33","author":"Mishra-Kalyani","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2022.06.002_bib0205","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hernan","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.canrad.2022.06.002_bib0210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2307\/2531628","article-title":"Continual reassessment method: a practical design for phase 1\u00a0clinical trials in cancer","volume":"46","author":"O\u2019Quigley","year":"1990","journal-title":"Biometrics"},{"key":"10.1016\/j.canrad.2022.06.002_bib0215","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.0006-341X.2000.01177.x","article-title":"Sequential designs for phase I clinical trials with late-onset toxicities","volume":"56","author":"Cheung","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.canrad.2022.06.002_bib0220","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12874-020-01012-z","article-title":"Practicalities in running early-phase trials using the time-to-event continual reassessment method (TiTE-CRM) for interventions with long toxicity periods using two radiotherapy oncology trials as examples","volume":"20","author":"van Werkhoven","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.canrad.2022.06.002_bib0225","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canrad.2021.11.008","article-title":"Tumour and normal tissue radiosensitivity","volume":"26","author":"Lapierre","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2022.06.002_bib0115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fonc.2017.00083","article-title":"Data-based radiation oncology: design of clinical trials in the toxicity biomarkers era","volume":"7","author":"Azria","year":"2017","journal-title":"Front Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321822001093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321822001093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:36:11Z","timestamp":1761136571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321822001093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":23,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1278321822001093"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2022.06.002","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Essais cliniques en Oncologie Radioth\u00e9rapie\u00a0: r\u00e9flexion m\u00e9thodologique","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2022.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}